Total Number of Shares and Voting Rights
On January 31, 2020
| Total number of outstanding shares |
Theoretical voting rights | Exercisable voting rights (minus treasury shares) |
| 63,498,801 | 63,498,801 | 63,164,831 |
Last updated on
Last updated on
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.